We are live on
!
Find out more
TWM
Tolleson Wealth Management Portfolio holdings
AUM
$742M
1-Year Est. Return
17.39%
This Fund
S&P 500
This Quarter
Est. Return
+7.43%
1 Year Est. Return
+17.39%
3 Year Est. Return
+56.19%
5 Year Est. Return
+54.12%
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$40M
(+12%)
Cap. Flow
+$15.9M
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
72.41%
Holding
75
New
1
Increased
13
Reduced
7
Closed
4
Avg Time Held
6.7
quarters
Top 10 Avg Time Held
4.9
quarters
Top 20 Avg Time Held
5.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR MSCI USA StrategicFactors ETF
QUS
|
+$7.2M |
| 2 |
iShares MSCI Intl Quality Factor ETF
IQLT
|
+$4.97M |
| 3 |
iShares MSCI Emerging Markets Asia ETF
EEMA
|
+$3.05M |
| 4 |
Vanguard FTSE Pacific ETF
VPL
|
+$2.92M |
| 5 |
Schwab US Broad Market ETF
SCHB
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$3.05M |
| 2 |
iShares MSCI EAFE Min Vol Factor ETF
EFAV
|
+$1.5M |
| 3 |
Energy Transfer Partners
ET
|
+$942K |
| 4 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$653K |
| 5 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$342K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.16% |
| 2 | Healthcare | 3.57% |
| 3 | Financials | 1.77% |
| 4 | Technology | 1.57% |
| 5 | Energy | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.59B
| $129M | 34.71% |
1,078,182
+61,802
| +6% | +$7.2M |
2020 Q1
5 quarters
|
|
|
2
iShares MSCI Emerging Markets Asia ETF
EEMA
$855M
| $22.7M | 6.13% |
245,804
+33,394
| +16% | +$3.05M |
2020 Q1
5 quarters
|
|
|
3
Vanguard FTSE Pacific ETF
VPL
$8.83B
| $20.5M | 5.53% |
249,467
+35,175
| +16% | +$2.92M |
2020 Q1
5 quarters
|
|
|
4
iShares Core S&P Total US Stock Market ETF
ITOT
$97.9B
| $18.6M | 5.02% |
188,775
-3,554
| -2% | -$342K |
2019 Q3
7 quarters
|
|
5
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $17M | 4.57% |
39,619
+563
| +1% | +$235K |
2018 Q4
10 quarters
|
|
6
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
| $16.6M | 4.48% |
146,754
-1,378
| -0.9% | -$147K |
2020 Q1
5 quarters
|
|
7
Vanguard FTSE All-World ex-US ETF
VEU
$67.8B
| $13M | 3.5% |
205,057
+14,550
| +8% | +$920K |
2019 Q3
7 quarters
|
|
|
RETA
8
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $11.5M | 3.09% |
81,000
-27,000
| -25% | -$3.05M |
2021 Q1
1 quarter
|
|
|
9
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.27B
| $10.3M | 2.77% |
135,894
-19,855
| -13% | -$1.5M |
2020 Q1
5 quarters
|
|
10
iShares MSCI EAFE ETF
EFA
$76.5B
| $9.65M | 2.6% |
122,359
| – | – |
2019 Q3
7 quarters
|
|
|
11
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
| $8.23M | 2.22% |
213,357
+128,785
| +152% | +$4.97M |
2020 Q4
2 quarters
|
|
12
iShares Russell Mid-Cap ETF
IWR
$56.6B
| $7.77M | 2.09% |
98,062
| – | – |
2019 Q3
7 quarters
|
|
13
iShares Russell 1000 Growth ETF
IWF
$130B
| $6.69M | 1.8% |
98,616
| – | – |
2019 Q3
7 quarters
|
|
14
iShares Russell 1000 Value ETF
IWD
$83.2B
| $5.46M | 1.47% |
34,455
| – | – |
2019 Q3
7 quarters
|
|
15
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $4.96M | 1.34% |
56,321
+4,716
| +9% | +$412K |
2018 Q4
10 quarters
|
|
16
iShares MSCI USA Min Vol Factor ETF
USMV
$23.9B
| $4.82M | 1.3% |
65,538
-1,130
| -2% | -$81.6K |
2018 Q4
10 quarters
|
|
17
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.89B
| $4.61M | 1.24% |
48,801
| – | – |
2019 Q3
7 quarters
|
|
18
iShares Core US Aggregate Bond ETF
AGG
$137B
| $4.12M | 1.11% |
35,720
+2,919
| +9% | +$334K |
2018 Q4
10 quarters
|
|
19
Vanguard Russell 3000 ETF
VTHR
$4.97B
| $3.33M | 0.9% |
16,701
| – | – |
2021 Q1
1 quarter
|
|
20
iShares Russell 3000 ETF
IWV
$20.6B
| $2.97M | 0.8% |
11,608
+279
| +2% | +$69.6K |
2018 Q4
10 quarters
|
|
21
iShares National Muni Bond ETF
MUB
$48.6B
| $2.93M | 0.79% |
24,988
+3,363
| +16% | +$393K |
2020 Q2
4 quarters
|
|
22
Mastercard
MA
$521B
| $2.76M | 0.74% |
7,553
| – | – |
2018 Q4
10 quarters
|
|
23
Visa
V
$731B
| $2.45M | 0.66% |
10,481
| – | – |
2018 Q4
10 quarters
|
|
24
iShares S&P 500 Growth ETF
IVW
$79.8B
| $2.08M | 0.56% |
28,651
| – | – |
2018 Q4
10 quarters
|
|
|
25
Schwab US Broad Market ETF
SCHB
$45.3B
| $2.04M | 0.55% |
117,138
+59,460
| +103% | +$1.01M |
2020 Q1
5 quarters
|
|
Similar funds
WIC
NC
CPC
SIC
LGA
TIP
CG
SAM
Tolleson Wealth Management's Q2 2021 Portfolio in Review
As of Q2 2021, Tolleson Wealth Management held 75 positions worth $371M, up 12% from $331M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Tolleson Wealth Management deployed $15.9M of net new capital in Q2 2021, opening 1 new position and adding to 13 existing holdings. Its largest new stake was Novavax: 1,000 shares worth $212K.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 90% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $3.05M trimmed.
- Tolleson Wealth Management's largest Q2 2021 buy was Novavax: 1,000 shares worth $212K.
- Tolleson Wealth Management added most to State Street SPDR MSCI USA StrategicFactors ETF in Q2 2021, an estimated $7.2M increase.
- Tolleson Wealth Management's biggest Q2 2021 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $3.05M.
- Tolleson Wealth Management fully exited Energy Transfer Partners in Q2 2021, selling an estimated $942K.
- Tolleson Wealth Management's ten largest holdings make up 72% of its $371M portfolio in Q2 2021.
- Tolleson Wealth Management opened 1 new position and closed 4 in Q2 2021.
- Tolleson Wealth Management's portfolio value rose 12% quarter-over-quarter to $371M.
Based on Tolleson Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.